Senores Pharmaceuticals Sets Price Band For IPO
Senores Pharmaceuticals Ltd. will launch its initial public offering on Dec. 20 at a price band of Rs 372 to Rs 391 per share.
The Ahmedabad-based pharmaceutical firm's IPO will comprise of a fresh issue of shares worth Rs 500 crore, and an offer-for-sale of 21 lakh shares by promoters and other shareholders worth Rs 82.1 crore. The maiden issue will be worth Rs 582.11 crore, and the market value at the upper end of the price band will be Rs 1,801 crore.
Promoters Swapnil Jatinbhai Shah and Ashokkumar Vijaysinh Barot are offloading 2.5 lakh and 5.5 lakh shares, respectively. Other shareholders selling shares include Sangeeta Mukur Barot and Prakash M Sanghvi.
The anchor book portion for the IPO will be launched on Dec. 19. Following the public issue, shares of Senores Pharmaceuticals will be listed on the NSE and the BSE.
Equirus Capital Pvt., Ambit Pvt., and Nuvama Wealth Management Ltd. are the book-running lead managers for the IPO, whereas Link Intime India Pvt. is the registrar for the issue.
Use Of Proceeds
The company proposes to use the proceeds of the issue:
As an investment in subsidiary Havix Group Inc. to fund capital expenditure requirements for setting up a sterile-injection manufacturing facility in Atlanta.
Repayment of borrowings by the company and its subsidiary.
Funding the working capital requirements of the company and its subsidiaries.
Funding inorganic growth through acquisition and other initiatives and general corporate purposes.
Senores Pharmaceuticals Business
Senores Pharmaceuticals Ltd. is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of US, Canada and United Kingdom across various therapeutic areas and dosage forms. They have a presence in emerging markets across 43 countries. The company also manufactures critical care injectables and APIs.
As of Nov. 30, 2024, the pharmaceutical maker had Rs 171.87 crore of debt on its books.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.